qventus.comHealthcare / Healthcare softwareFounded: 2012Funding to Date: $105.38MM
Qventus is a developer of an AI-based software platform that aims to help hospital teams make better operational decisions. With a mission to reduce manual work in healthcare, the company includes tools for perioperative and inpatient services such as governance documentation and analysis assessment for teams. Qventus was founded by Brent Newhouse, Ian Christopher, and Mudit Garg in 2012 and is headquartered in Mountain View, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/28/2022 | Series C-1 | $3MM | $xx.xx | $237.22MM | Bessemer Venture Partners, Mayfield Fund, Norwest Venture Partners, Premier, Thedacare, Thomas H. Lee Partners | |
Price per Share
$xx.xx
Shares Outstanding
670,455
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bessemer Venture Partners, Mayfield Fund, Norwest Venture Partners, Premier, Thedacare, Thomas H. Lee Partners
|
||||||
02/28/2022 | Series C-2 | $5.09MM | $xx.xx | $237.22MM | Bessemer Venture Partners, Mayfield Fund, Norwest Venture Partners, Premier, Thedacare, Thomas H. Lee Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,209,669
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bessemer Venture Partners, Mayfield Fund, Norwest Venture Partners, Premier, Thedacare, Thomas H. Lee Partners
|
||||||
02/28/2022 | Series C | $50.91MM | $xx.xx | $237.22MM | Bessemer Venture Partners, Mayfield Fund, Norwest Venture Partners, Premier, Thedacare, Thomas H. Lee Partners | |
Price per Share
$xx.xx
Shares Outstanding
9,670,146
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bessemer Venture Partners, Mayfield Fund, Norwest Venture Partners, Premier, Thedacare, Thomas H. Lee Partners
|
||||||
05/14/2018 | Series B | $32.75MM | $xx.xx | $128.36MM | Bessemer Venture Partners, Mayfield Fund, Newyork-Presbyterian Hospital, Norwest Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
8,544,684
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bessemer Venture Partners, Mayfield Fund, Newyork-Presbyterian Hospital, Norwest Venture Partners
|
||||||
11/16/2016 | Series A-1 | $99,999.00 | $xx.xx | $28.94MM | Mayfield, Norwest Venture Partners, Stanford Startx Fund, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
118,934
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Mayfield, Norwest Venture Partners, Stanford Startx Fund, Y Combinator
|
||||||
11/16/2016 | Series A-3 | $249,999.00 | $xx.xx | $28.94MM | Mayfield, Norwest Venture Partners, Stanford Startx Fund, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
193,588
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Mayfield, Norwest Venture Partners, Stanford Startx Fund, Y Combinator
|
||||||
11/16/2016 | Series A-2 | $1.11MM | $xx.xx | $28.94MM | Mayfield, Norwest Venture Partners, Stanford Startx Fund, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
1,070,563
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Mayfield, Norwest Venture Partners, Stanford Startx Fund, Y Combinator
|
||||||
11/16/2016 | Series A | $11.92MM | $xx.xx | $28.94MM | Mayfield, Norwest Venture Partners, Stanford Startx Fund, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
8,582,044
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Mayfield, Norwest Venture Partners, Stanford Startx Fund, Y Combinator
|
||||||
12/01/2014 | Series Seed | $250,079.00 | $xx.xx | $5MM | Fundersclub, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
454,772
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Fundersclub, Y Combinator
|